Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Enterprise Case Studies

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>

27 June 2014: Trading quality: Roubini intern enjoys prominent placement

UCL student Jakub Szukalski (BA Economics and Business with East European Studies, second year) was looking for a productive way to spend the months leading into his final year at UCL. So he jumped at the chance of an internship with Roubini Global Economics (RGE) – the research company headed up by the distinguished macro-economist Nouriel Roubini. The partnership proved to be a win-win situation. More...

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>